Tissue Regenix cited BioMedGPS SmartTRAK as a source when compiling their Corporate Overview for presentation at the Jeffries Healthcare Conference.

BioMedGPS Announces SmartTRAK 2.0 Launch — a Significantly Enhanced Life Science Market Business Intelligence Platform

BioMedGPS launches a mobile-friendly, significantly enhanced and modernized interface to its SmartTRAK life sciences business intelligence platform. SmartTRAK 2.0 will even more effectively provide company, market and product data to the orthopedics, wound care and neuro therapies industries.

There are exciting things happening at SmartTRAK, including rapid growth of our Wound Care business.  To help manage its growth, SmartTRAK is very excited to announce that Thea Bowers is joining our Wound Care team.  

We're happy to introduce you to the newest member of our team, Michelle Calderon, Orthopedics Account Manager.

SmartTRAK revealed its new logo on June 5, 2017, at its annual Orthopedic Analysts meeting in Ocean Grove, New Jersey (down at the Jersey Shore). 

Another Great SmartTRAK Customer Testimonial

SmartTRAK user Cristina Acevedo, R&D and Operations Manager, tells how she uses SmartTRAK to stay on top of wound care business developments and rapidly shares this intel with her team.

SmartTRAK Customer Testimonial - R&D and Operations Manager.

Nevro:  The One to Beat!

In an interview with BioMedGPS, Nevro CEO Rami Elghandour discussed the Company’s success, its growth strategies, and some of the challenges of being the one to beat in the spinal cord stimulation (SCS) market.

Since disrupting the market with its paresthesia-free high frequency (HF10) Senza SCS System, Nevro has set a new standard of care for SCS with unparalleled clinical evidence and success in treating chronic intractable leg and back pain.

And Anne Staylor is off and running!

Meet with Anne Staylor at #INS2017, Senior SmartTRAK Analyst and Managing Editor, and get your questions answered about SmartTRAK and Neuro Therapies business, market and competitive intelligence. 

Interview with Hal Mathews, MD of Paradigm Spine, Chris Lyons of Medtronic Spine & Biologics and Don Urbanowicz of Urbanowicz Consulting.

On October 25, 2016, Capital One, BioMedGPS and Kinsella Group sponsored a panel discussion prior to NASS 2016. Multiple panel members participated in the event which covered a variety of topics. The discussion featured in the excerpt below focuses on “Insights And Perspective: Medtronic and Paradigm Spine” with Hal Mathews, M.D., MBA – Executive Vice President and Chief Medical Officer for Paradigm Spine, Chris Lyons – Director of Global Business Development for Medtronic Spine & Biologics and Don Urbanowicz of Urbanowicz Consulting.